Tobacco smoking rates are decreasing in people with major depression and substance use disorder

Despite decline, smoking cessation efforts still critical for people with substance use or other psychiatric disorders [] [View as webpage / Share]( NIDA emails have a new look. You are receiving this email because you previously signed up to receive digests. You may view [topics of interest and subscriber preferences]( to alter frequency. [NIH National Institute on Drug Abuse] NEWS [Male nurse consulting a man and a woman in medical setting.]( Tobacco smoking rates are decreasing in people with major depression and substance use disorder Significant reductions in cigarette use were found among U.S. adults with major depression, substance use disorder, or both from 2006 to 2019, according to a new analysis of nationally representative survey data published today in JAMA. The study was conducted by researchers at the National Institute on Drug Abuse, part of the National Institutes of Health, and the Substance Abuse and Mental Health Services Administration. These findings suggest that groups at higher risk of cigarette smoking can be reached by, and may have benefitted from, tobacco use prevention and cessation efforts that have led to significant declines in tobacco use in the general population. At the same time, the findings highlight remaining disparities, documenting higher smoking rates in people with psychiatric disorders than in those without. [View Press Release]( Stay Connected [facebook]([twitter]([linkedin]([youtube]( --------------------------------------------------------------- Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your [Subscriber Preferences Page](. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit [subscriberhelp.govdelivery.com](. This service is provided to you at no charge by [National Institute on Drug Abuse](. --------------------------------------------------------------- This email was sent to {EMAIL} using govDelivery Communications Cloud on behalf of: National Institute on Drug Abuse · 3WFN MSC 6024 · 301 North Stonestreet Ave · Bethesda, MD 20892 [GovDelivery logo](